Clinical trial
Blood Tumor Markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
NCT00898508 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Tumor Markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
- Lead sponsor
- City of Hope Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- June 6, 2019
- Enrollment
- 563 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer